Larry Biegelsen

Q: What is Larry Biegelsen's success rate?

Larry Biegelsen currently has a success rate of 88.55272915437061.

Q: What is the average return of Larry Biegelsen's calls?

Their stock ratings have generated an average return of 5.460520745565982.

Wells Fargo | Healthcare

Larry Biegelsen is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #1920 out of 4655 analysts, they have issued 81 stock ratings with a success rate of 88.55% and an average return of 5.46%.

Larry Biegelsen has a well-established track record, with 81 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.55% and an average return of 5.46%, underscoring their expertise and ability to identify winning opportunities for investors.

#1920

Out of 4655

Total Ratings

+88.55%

Success Rate

+5.46%

Average Return

Recent Ratings Analysis

HTFL

Buy

May 15, 2026

Target

$37.00

Current

$28.32

Performance

-0.02%

Larry Biegelsen rated HTFL as Overweight on May 15, 2026, setting a price target of 37. Shares have remained stable near 28.315, leaving the 37 target still in play.

TFX

Hold

May 08, 2026

Target

$138.00

Current

$129.71

Performance

-2.52%

On May 08, 2026, TFX was given a Equal-Weight rating by Larry Biegelsen, with a target price of 138. Market indecision, reflected in sideways trading near 129.71, supported the cautious call.

GMED

Buy

May 08, 2026

Target

$103.00

Current

$76.64

Performance

-1.68%

GMED received a Overweight rating from Larry Biegelsen on May 08, 2026, aiming for 103. Price action was muted, as shares hovered around 76.64 despite the bullish outlook.

ENOV

Buy

May 08, 2026

Target

$40.00

Current

$24.29

Performance

-8.41%

On May 08, 2026, Larry Biegelsen published a Overweight outlook on ENOV, with a target of 40. Market action contradicted the Buy thesis, as shares slipped to 24.29.

ATEC

Buy

May 07, 2026

Target

$14.00

Current

$7.66

Performance

-1.16%

Larry Biegelsen on May 07, 2026 assigned ATEC a Overweight rating, with a price target of 14. The recommendation remains pending validation as shares consolidate around 7.66.

RXST

Hold

May 07, 2026

Target

$9.00

Current

$5.68

Performance

-2.07%

On May 07, 2026, Larry Biegelsen reaffirmed RXST with a Equal-Weight rating, targeting 9. The neutral call matched muted market action of -2.07%.

ALC

Buy

May 07, 2026

Target

$86.00

Current

$63.64

Performance

-0.38%

ALC was rated Overweight by Larry Biegelsen on May 07, 2026, with a price objective of 86. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

SOLV

Hold

May 06, 2026

Target

$70.00

Current

$74.26

Performance

4.59%

On May 06, 2026, Larry Biegelsen initiated coverage on SOLV with a Equal-Weight rating and target of 70. The stock’s lack of movement around 74.26 aligned with a cautious approach.

IART

Hold

May 06, 2026

Target

$15.00

Current

$14.10

Performance

0.71%

Larry Biegelsen issued a Equal-Weight recommendation for IART on May 06, 2026, price target set at 15. The rating was appropriate for a consolidating market trading near 14.1.

INSP

Hold

May 05, 2026

Target

$56.00

Current

$40.05

Performance

-16.99%

On May 05, 2026, INSP was evaluated by Larry Biegelsen, who gave a Equal-Weight rating and target of 56. The Hold call avoided chasing into subsequent weakness of 16.99%.

NVCR

Hold

May 04, 2026

Target

$17.00

Current

$17.58

Performance

3.84%

Larry Biegelsen rated NVCR as Equal-Weight on May 04, 2026, setting a price target of 17. The Hold stance appears justified, as shares hovered around 17.58 with a 3.84% move.

MMSI

Hold

May 01, 2026

Target

$74.00

Current

$61.36

Performance

—

On May 01, 2026, MMSI was given a Equal-Weight rating by Larry Biegelsen, with a target price of 74. Market indecision, reflected in sideways trading near 61.36, supported the cautious call.

SYK

Buy

May 01, 2026

Target

$418.00

Current

$306.76

Performance

—

SYK received a Overweight rating from Larry Biegelsen on May 01, 2026, aiming for 418. Price action was muted, as shares hovered around 306.76 despite the bullish outlook.

CNMD

Hold

May 01, 2026

Target

$39.00

Current

$35.49

Performance

—

On May 01, 2026, Larry Biegelsen published a Equal-Weight outlook on CNMD, with a target of 39. Sideways action left the Hold view intact, with no major move since 35.49.

GKOS

Buy

Apr 30, 2026

Target

$138.00

Current

$144.01

Performance

0.24%

Larry Biegelsen on Apr 30, 2026 assigned GKOS a Overweight rating, with a price target of 138. The recommendation remains pending validation as shares consolidate around 144.01.

GEHC

Buy

Apr 30, 2026

Target

$75.00

Current

$60.76

Performance

-0.13%

On Apr 30, 2026, Larry Biegelsen reaffirmed GEHC with a Overweight rating, targeting 75. Market indecision has kept the 75 target in a holding pattern.

AXGN

Buy

Apr 29, 2026

Target

$48.00

Current

$40.99

Performance

-1.87%

AXGN was rated Overweight by Larry Biegelsen on Apr 29, 2026, with a price objective of 48. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ZBH

Hold

Apr 29, 2026

Target

$90.00

Current

$83.70

Performance

4.53%

On Apr 29, 2026, Larry Biegelsen initiated coverage on ZBH with a Equal-Weight rating and target of 90. The stock’s lack of movement around 83.7 aligned with a cautious approach.

BSX

Buy

Apr 23, 2026

Target

$75.00

Current

$52.68

Performance

-19.81%

Larry Biegelsen issued a Overweight recommendation for BSX on Apr 23, 2026, price target set at 75. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

JNJ

Buy

Apr 15, 2026

Target

$263.00

Current

$226.71

Performance

—

On Apr 15, 2026, JNJ was evaluated by Larry Biegelsen, who gave a Overweight rating and target of 263. So far, the Buy call awaits clearer momentum, with shares flat at 226.71.

MMED

Buy

Mar 31, 2026

Target

$26.00

Current

$10.80

Performance

-27.61%

Larry Biegelsen rated MMED as Overweight on Mar 31, 2026, setting a price target of 26. The stock has underperformed, dropping 27.61% despite the bullish target of 26.

AVR

Buy

Mar 11, 2026

Target

$16.00

Current

$7.24

Performance

8.22%

On Mar 11, 2026, AVR was given a Overweight rating by Larry Biegelsen, with a target price of 16. The stock rallied 8.22% after the rating, narrowing the gap to the target of 16 and validating the bullish stance.

BLCO

Hold

Feb 19, 2026

Target

$18.00

Current

$16.09

Performance

-8.84%

BLCO received a Equal-Weight rating from Larry Biegelsen on Feb 19, 2026, aiming for 18. The Hold stance proved prudent, with the market softening by 8.84%.

DXCM

Buy

Feb 13, 2026

Target

$93.00

Current

$61.63

Performance

-11.98%

On Feb 13, 2026, Larry Biegelsen published a Overweight outlook on DXCM, with a target of 93. Market action contradicted the Buy thesis, as shares slipped to 61.63.

EW

Buy

Feb 11, 2026

Target

$100.00

Current

$81.38

Performance

2.58%

Larry Biegelsen on Feb 11, 2026 assigned EW a Overweight rating, with a price target of 100. The recommendation remains pending validation as shares consolidate around 81.38.

PEN

Hold

Jan 15, 2026

Target

$374.00

Current

$322.32

Performance

-8.04%

On Jan 15, 2026, Larry Biegelsen reaffirmed PEN with a Equal-Weight rating, targeting 374. The Hold stance reflected market caution that was later justified.

KMTS

Buy

Dec 12, 2025

Target

$28.00

Current

$19.82

Performance

-24.26%

KMTS was rated Overweight by Larry Biegelsen on Dec 12, 2025, with a price objective of 28. This case shows how bullish projections can fail, with the stock now below 19.82.

COO

Hold

Dec 05, 2025

Target

$82.00

Current

$59.61

Performance

-26.77%

On Dec 05, 2025, Larry Biegelsen initiated coverage on COO with a Equal-Weight rating and target of 82. The rating matched the stock’s inability to hold above 59.61.

MDT

Buy

Nov 19, 2025

Target

$114.00

Current

$76.15

Performance

-24.11%

Larry Biegelsen issued a Overweight recommendation for MDT on Nov 19, 2025, price target set at 114. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TNDM

Hold

Nov 07, 2025

Target

$14.00

Current

$12.82

Performance

-21.16%

On Nov 07, 2025, TNDM was evaluated by Larry Biegelsen, who gave a Equal-Weight rating and target of 14. The Hold call avoided chasing into subsequent weakness of 21.16%.

ISRG

Buy

Oct 22, 2025

Target

$600.00

Current

$421.12

Performance

-20.10%

Larry Biegelsen rated ISRG as Overweight on Oct 22, 2025, setting a price target of 600. The stock has underperformed, dropping 20.10% despite the bullish target of 600.

HYPR

Hold

Aug 15, 2025

Target

$0.85

Current

$1.55

Performance

11.51%

On Aug 15, 2025, HYPR was given a Equal-Weight rating by Larry Biegelsen, with a target price of 0.85. The stock rallied from 1.55 to 1.55 after the Hold rating, surprising to the upside.

BAX

Hold

Aug 01, 2025

Target

$24.00

Current

$17.30

Performance

-21.22%

BAX received a Equal-Weight rating from Larry Biegelsen on Aug 01, 2025, aiming for 24. The Hold stance proved prudent, with the market softening by 21.22%.

LUNG

Hold

Aug 01, 2025

Target

$3.00

Current

$1.27

Performance

-21.12%

On Aug 01, 2025, Larry Biegelsen published a Equal-Weight outlook on LUNG, with a target of 3. Weakness in the stock, now at 1.27, supported the conservative rating.

NPCE

Buy

Jan 30, 2025

Target

$17.00

Current

$15.36

Performance

8.25%

Larry Biegelsen on Jan 30, 2025 assigned NPCE a Overweight rating, with a price target of 17. The Buy call aligned well with market performance, producing a gain of 8.25%.

NARI

Hold

Jan 07, 2025

Target

$80.00

Current

$79.97

Performance

0.65%

On Jan 07, 2025, Larry Biegelsen reaffirmed NARI with a Equal-Weight rating, targeting 80. The neutral call matched muted market action of 0.65%.

Frequency Asked Questions

Who is Larry Biegelsen?

Larry Biegelsen is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Larry Biegelsen's success rate?

Larry Biegelsen currently has a success rate of +88.55%.

How many ratings has Larry Biegelsen issued?

Larry Biegelsen has issued 81 stock ratings so far.

What is the average return of Larry Biegelsen's calls?

Their stock ratings have generated an average return of +5.46%.

What is Larry Biegelsen's ranking?

Larry Biegelsen is ranked #1920 out of 4655 analysts.

What types of ratings does Larry Biegelsen give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Larry Biegelsen?

You can follow Larry Biegelsen by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Larry Biegelsen?

Their latest rating was a Buy on HTFL issued on 2026-05-15.